Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies, especially in Indian Market. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson’s and improve the quality of life of millions who are affected by Parkinson’s disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson’s diseases in India with very high affordability and accessibility.

About Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurologic disorders, affecting approximately 1% of individuals older than 60 years and causing progressive disability that can be slowed but not halted, by treatment. Parkinson’s disease is a movement disorder that causes involuntary movements and rigidity, as well as abnormal walking and posture. It is caused by an imbalance between two chemicals that transmit signals from the brain, dopamine, and acetylcholine.

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions, or industry conditions or events may be “forward-looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance, or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Tedco Education Sets Up Its New Campus Goodrich Tedco School of Bakey Arts in Association with Goodrich Carbohydrates and Chef Sahil Mehta

May 21: Over the past few years, the food services industry has emerged as a critical segment of the Indian economy. In fact, this vibrant industry has witnessed rapid growth in the recent past, and experts suggest that it will continue to grow in the coming years. Looking at this growth opportunity, Tedco Education, a […]

Read More
Business

InkQuills Publishing House- An Evolutionary and Approachable Go-to Solution for Writer and Authors

May 21: InkQuills Publishing House is India’s fastest growing self-publishing house. They have published more than 100+ books and have helped more than 2000+ authors realize their potential. InkQuills has a global network for paperback and eBook distribution. Their worldwide reach helps you gather a vast readership and develop a fan base in more than […]

Read More
Business

2nd day of the Cinetalkies, Azadi ka Amrit Mahotsav hosted by Sanskar Bharti concludes with aspiring smiles

Moderator- Raviraj Pramani, Durga Jasraj,Anu Malik,Bharat Bala discussing about Bharatiya Cinema Sangeet. ~it was an experience in its own way, Cinetalkies the one-of-a-kind seminar gave us stories worth remembering and the future outlook of the cinema industry~ Mumbai, 21 th May 2022: Sanskar Bharti, one of the well-known organsiation working towards the promotion of Indian art and […]

Read More